Conforms to 93/112/EC and ISO 11014-1
Material Safety Data Sheet
Iodoacetamide, 500mg
7230
1859621
CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
9/15/2005
9/15/2005
Product name
Supplier
Manufacturer
Product No.
MSDS#
Validation Date
Print Date
In Case of Emergency
Section 1. Chemical Product and Company Identification
Responsible Name MSDS Administrator
Synonyms
IODOACETAMIDE; ALPHA-IODOACETAMIDE; 2-IODOACETAMIDE; MONOIODOACETAMIDE; SURAUTO; USAF
D-1
Intended Use Refer to the instruction booklet for proper and intended use. Otherwise, contact supplier for specific applications.
Eng
In USA:
In Europe:
Pierce
Perbio Science
P.O. Box 117
Industriezone III
Rockford, IL 61105 Industrielaan 27
USA
9320 Erembodegem-Aalst
815.968.0747 or
Belgium
1.800.874.3723
Tel:+32 53 83 44 04
Fax:+32 53 83 76 38
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
USA
815.968.0747 or
1.800.874.3723
Substance/Preparation
Substance
:
Section 2. Composition, Information on Ingredients
CAS number
Ingredient name
%
EC number
Classification
Iodoacetamide, 500mg
144-48-9
98 - 100
205-630-1
Carc. Cat. 2; R45
T; R25
R42/43
Dermal contact. Eye contact. Inhalation. Ingestion.
Emergency Overview
Medical Conditions Aggravated
by Overexposure:
Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in one or
many human organs.
Not available.
Overexposure /Signs/Symptoms
Section 3. Hazards Identification
Routes of Entry
Carcinogenic Effects Data
Do not ingest. Wash thoroughly after handling. Risk of cancer depends on duration and level of exposure.
CARCINOGENIC EFFECTS: Classified None. by OSHA, None. by NIOSH.
MUTAGENIC EFFECTS: Classified POSSIBLE for human.
TERATOGENIC EFFECTS: Not available.
Review the most current and approved institutional guideline, protocol, standard operating procedure(s) and MSDS(s)
for the proper handling of institutional materials/equipment associated with the use of this product.
Warning!
HARMFUL IF SWALLOWED.
POSSIBLE CANCER HAZARD.
MAY CAUSE